THE PLASMA “AMMONIA” AND GLUTAMINE CONTENT IN PATIENTS WITH HEPATIC COMA

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston, Mass.}

^{Department of Medicine, Harvard Medical School, Boston, Mass.}

^{National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, United States Public Health Service, Bethesda, Md.}

On assignment from the National Institute of Arthritis and Metabolic Diseases, United States Public Health Service.

This work was done under the sponsorship of the Commission on Liver Disease, Armed Forces Epidemiological Board, and was supported in part by the office of the Surgeon General, Department of the Army, and in part by a grant from Merck and Company, Inc., Rahway, N. J., to Harvard University.

Find articles by Seegmiller, J. in: PubMed | Google Scholar

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston, Mass.}

^{Department of Medicine, Harvard Medical School, Boston, Mass.}

^{National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, United States Public Health Service, Bethesda, Md.}

On assignment from the National Institute of Arthritis and Metabolic Diseases, United States Public Health Service.

This work was done under the sponsorship of the Commission on Liver Disease, Armed Forces Epidemiological Board, and was supported in part by the office of the Surgeon General, Department of the Army, and in part by a grant from Merck and Company, Inc., Rahway, N. J., to Harvard University.

Find articles by Schwartz, R. in: PubMed | Google Scholar

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston, Mass.}

^{Department of Medicine, Harvard Medical School, Boston, Mass.}

^{National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, United States Public Health Service, Bethesda, Md.}

On assignment from the National Institute of Arthritis and Metabolic Diseases, United States Public Health Service.

This work was done under the sponsorship of the Commission on Liver Disease, Armed Forces Epidemiological Board, and was supported in part by the office of the Surgeon General, Department of the Army, and in part by a grant from Merck and Company, Inc., Rahway, N. J., to Harvard University.

Find articles by Davidson, C. in: PubMed | Google Scholar